Skip to content

    Styrenix Performance Materials Limited

    STYRENIXMixed
    Chemicals·12 Nov 2025
    Management Summary

    Styrenix Performance Materials reported a mixed Q2 FY26, with standalone revenue declining 5.8% YoY to ₹615 crores and PBDIT falling 14.94% YoY for H1 FY26. Consolidated results, including the newly acquired Thailand business, showed Q2 revenue at ₹799 crores and PBDIT at ₹88.4 crores. Management highlighted strong ABS performance in India, contributing to an anticipated 10% volume growth for the full year, while the Thailand operations are expected to remain flattish in FY26 with long-term strategic value. The company is progressing with its ₹350 crores ABS expansion capex in India, with ₹40 crores spent in H1 FY26.

    Highlights

    8
    • Standalone Q2 FY26 Revenue declined 5.8% YoY to ₹615 crores.

    • Standalone Q2 FY26 PBDIT stood at ₹81.8 crores, with a margin of 13.3%.

    • Standalone H1 FY26 PBDIT declined 14.94% YoY to ₹167.9 crores.

    • Consolidated Q2 FY26 Revenue was ₹799 crores, with PBDIT at ₹88.4 crores (11.1% margin).

    • Consolidated H1 FY26 Sales Volume reached 124.7 KT, with Revenue at ₹1,742 crores.

    • India operations anticipate approximately 10% volume growth for FY26.

    • Thailand operations are expected to be flattish in FY26, with long-term value addition.

    • ₹350 crores capex for ABS Phase 1 expansion in India is underway, with ₹40 crores spent in H1 FY26.

    What Changed2

    vs Q3 FY26

    Guidance items3 → 11 (+8)Q&A highlights8 → 3 (-5)

    Key financials

    Single quarter

    06 metrics
    1. 01Standalone Revenue₹615 Cr-5.8%YoY
    2. 02Standalone PBDIT₹81.8 Cr-22.2%YoY
    3. 03Standalone PBDIT Margin13.3%
    4. 04Consolidated Revenue₹799 Cr-15.3%QoQ
    5. 05Consolidated PBDIT₹88.4 Cr-10.7%QoQ

    Guidance & targets

    11
    CategoryTargetPriority
    Capex
    ABS Phase 1 Capex Completion
    mid to end of next financial year
    Medium
    Capex
    India Phase 1 Capex (Total)
    ₹350 crores
    High
    Capex
    India Phase 1 Capex (H1 FY26 Spend)
    ₹40 crores
    High
    Capex
    India Capex Duration
    2 years
    High
    Volume
    India Overall Volume Growth
    10%
    Medium
    Volume
    Thailand Volume Growth
    flattish
    Medium
    Volume
    Thailand Volume Growth
    some update
    Low
    Capacity
    Thailand Capacity Utilization
    significantly higher
    Low
    Capacity
    ABS Capacity Utilization (India)
    relatively full
    High
    Sales
    Polystyrene (PS) Sales
    generally better
    Low
    Sales
    Dubai/GCC Sales Contribution
    more next year
    Low

    Risks & concerns

    7
    RiskSeverity

    Uncertainties in Thailand Operations

    Management stated 'some level of uncertainties around Thailand' and refrained from giving forward-looking EBITDA projections for the region.Management acknowledged

    medium

    Competitive Intensity in ABS Market

    Analysts raised concerns about new capacities and potential margin pressure, but management believes the market is underserved and they haven't seen significant impact yet.Analyst downplayed

    medium

    China Overcapacity and Imports

    Analyst noted China's increasing capacities and imports; management acknowledged global overcapacity but stated they serve niche markets and manage imports.Analyst acknowledged

    medium

    Brand Transition Impact in Thailand

    The transition from the INEOS brand to Absolac in Thailand required validation, leading to a 5-10% loss in overall volumes, which they expect to recover.Management acknowledged

    medium

    Areas of Evasion(3)

    • Specific EBITDA projections for Thailand
    • Exact market share loss numbers for Thailand
    • Specific timelines for Thailand's full ramp-up

    Q&A highlights

    3

    “Overall, for this year, we are estimating the growth to be flattish in Thailand... But overall, in the entire year, we are not giving any kind of forward-looking EBITDA projections right now because there are some level of uncertainties around Thailand.”

    Analyst sought clarity on the financial contribution and future outlook of the recently acquired Thailand business, which management acknowledged had uncertainties and would be a long-term value driver rather than a short-term gain.

    asked by Aditya Khetan

    3 min read7 chapters

    Detailed Narrative

    01

    Q2 & H1 FY26 Financial Performance: A Mixed Picture

    Styrenix Performance Materials reported a mixed performance for Q2 FY26. Standalone revenue for Q2 FY26 decreased by 5.8% YoY to ₹615 crores, with PBDIT at ₹81.8 crores, representing a 13.3% margin. For H1 FY26, standalone revenue was ₹1,336 crores, a 1.18% YoY decrease, and PBDIT stood at ₹167.9 crores, a 14.94% YoY decline. Consolidated results, which include the Thailand subsidiary, showed Q2 FY26 revenue at ₹799 crores and PBDIT at ₹88.4 crores (11.1% margin), reflecting a QoQ decline from Q1 FY26.

    02

    Standalone Operations: Volume Growth Driven by ABS

    The standalone business saw Q2 FY26 sales volume of 45.2 KT, an 8.1% increase YoY, but a 12.7% QoQ decrease. H1 FY26 standalone sales volume grew by 7.6% YoY to 97 KT. Management indicated that most of this growth came from the ABS segment, with polystyrene (PS) sales remaining largely flat due to impacts on household appliances and air conditioning. The company anticipates approximately 10% overall volume growth for India in FY26, with the second half expected to be better than the first.

    03

    Consolidated Performance & Thailand's Initial Contribution

    The consolidated figures, incorporating Styrenix Performance Materials Thailand Limited (acquired January '25), showed Q2 FY26 sales volume at 57.5 KT and H1 FY26 volume at 124.7 KT. Thailand's contribution to H1 FY26 volumes was 32 KT (17 KT in Q1, 15 KT in Q2). Management expects Thailand's growth to be flattish for FY26, with significant uncertainties, and no forward-looking EBITDA projections were provided for the region, emphasizing its medium-to-long term strategic value.

    04

    Strategic Capex for ABS Expansion in India

    The company is proceeding with its Phase 1 ABS expansion capex in India, with a total planned spend of approximately ₹350 crores. In H1 FY26, ₹40 crores has been spent on this capex. Management expects the project to be completed sometime between the mid to end of the next financial year (FY27), with the entire capex spend occurring within two years. The funding for this capex will initially come from internal accruals, with borrowings expected in the near future.

    05

    Market Outlook & Competitive Landscape for ABS & PS

    Management noted that the ABS market in India remains underserved, providing opportunities for import substitution despite new capacities from competitors. They are running ABS capacities 'relatively full' and have not seen significant increases in competitive intensity or changes in margin profile. For PS, demand is expected to improve in the next two quarters, particularly in Q4, driven by sectors like air conditioning and refrigerators, which typically see higher sales of HIPS grades.

    06

    Raw Material Management and Pricing Strategy

    The company maintains minimal inventory, particularly for imported raw materials like styrene and acrylonitrile, to mitigate the impact of falling raw material prices. Most of the business operates on a formula-driven pricing model, allowing for the pass-through of raw material price fluctuations to customers. While some spot market opportunities exist, competitive intensity limits significant upside in margins.

    07

    International Expansion: Dubai Subsidiary & Thailand Market Share

    Styrenix incorporated a wholly-owned subsidiary, Styrenix Performance Materials FZE, in Dubai in September 2024, to serve as a long-term base for sales to the Middle East, Europe, and the U.S. Initial benefits from this entity are expected to materialize more next year. In Thailand, the transition from the INEOS brand to the local Absolac brand has led to a 5-10% loss in overall volumes, which management is confident in recovering over time through customer validation and sales efforts.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.